These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18928745)

  • 1. Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study.
    Gisbert JP; Luna M; González-Lama Y; Pousa ID; Velasco M; Moreno-Otero R; Maté J
    Gastroenterol Hepatol; 2008 Oct; 31(8):477-84. PubMed ID: 18928745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
    Gisbert JP; González-Lama Y; Maté J
    Inflamm Bowel Dis; 2007 May; 13(5):629-38. PubMed ID: 17243140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminosalicylates and effects on renal function in patients with Crohn's disease.
    de Jong DJ; Tielen J; Habraken CM; Wetzels JF; Naber AH
    Inflamm Bowel Dis; 2005 Nov; 11(11):972-6. PubMed ID: 16239842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
    Heap GA; So K; Weedon M; Edney N; Bewshea C; Singh A; Annese V; Beckly J; Buurman D; Chaudhary R; Cole AT; Cooper SC; Creed T; Cummings F; de Boer NK; D'Inca R; D'Souza R; Daneshmend TK; Delaney M; Dhar A; Direkze N; Dunckley P; Gaya DR; Gearry R; Gore S; Halfvarson J; Hart A; Hawkey CJ; Hoentjen F; Iqbal T; Irving P; Lal S; Lawrance I; Lees CW; Lockett M; Mann S; Mansfield J; Mowat C; Mulgrew CJ; Muller F; Murray C; Oram R; Orchard T; Parkes M; Phillips R; Pollok R; Radford-Smith G; Sebastian S; Sen S; Shirazi T; Silverberg M; Solomon L; Sturniolo GC; Thomas M; Tremelling M; Tsianos EV; Watts D; Weaver S; Weersma RK; Wesley E; Holden A; Ahmad T
    J Crohns Colitis; 2016 Feb; 10(2):149-58. PubMed ID: 26619893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of long-term treatment with 5-aminosalicylic acid.
    Patel H; Barr A; Jeejeebhoy KN
    Can J Gastroenterol; 2009 Mar; 23(3):170-6. PubMed ID: 19319380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey.
    Zallot C; Billioud V; Frimat L; Faure P; Peyrin-Biroulet L;
    J Crohns Colitis; 2013 Aug; 7(7):551-5. PubMed ID: 22999780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.
    Fraser JS; Muller AF; Smith DJ; Newman DJ; Lamb EJ
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1131-7. PubMed ID: 11472315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.
    Moss JG; Parry CM; Holt RCL; McWilliam SJ
    Eur J Med Res; 2022 Apr; 27(1):61. PubMed ID: 35488310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?
    Elseviers MM; D'Haens G; Lerebours E; Plane C; Stolear JC; Riegler G; Capasso G; Van Outryve M; Mishevska-Mukaetova P; Djuranovic S; Pelckmans P; De Broe ME;
    Clin Nephrol; 2004 Feb; 61(2):83-9. PubMed ID: 14989626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid).
    Klotz U
    Arzneimittelforschung; 2012 Feb; 62(2):53-8. PubMed ID: 22344548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.
    Carrat F; Seksik P; Colombel JF; Peyrin-Biroulet L; Beaugerie L;
    Aliment Pharmacol Ther; 2017 Feb; 45(4):533-541. PubMed ID: 27995656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Corrigan G; Stevens PE
    Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
    Cury DB; Moss AC
    Inflamm Bowel Dis; 2010 Aug; 16(8):1393-6. PubMed ID: 19998457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalazine-associated interstitial nephritis.
    World MJ; Stevens PE; Ashton MA; Rainford DJ
    Nephrol Dial Transplant; 1996 Apr; 11(4):614-21. PubMed ID: 8671848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
    Van Staa TP; Travis S; Leufkens HG; Logan RF
    Gastroenterology; 2004 Jun; 126(7):1733-9. PubMed ID: 15188168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.